Pathak, S., S, S., Banerjee, A., Marotta, F., Gopinath, M., Murugesan, R., . . . Sun, X. (2017). Review on comparative efficacy of bevacizumab, panitumumab and cetuximab antibody therapy with combination of FOLFOX-4 in KRAS-mutated colorectal cancer patients. Oncotarget.
استشهاد بنمط شيكاغوPathak, Surajit, et al. "Review On Comparative Efficacy of Bevacizumab, Panitumumab and Cetuximab Antibody Therapy With Combination of FOLFOX-4 in KRAS-mutated Colorectal Cancer Patients." Oncotarget 2017.
MLA استشهادPathak, Surajit, et al. "Review On Comparative Efficacy of Bevacizumab, Panitumumab and Cetuximab Antibody Therapy With Combination of FOLFOX-4 in KRAS-mutated Colorectal Cancer Patients." Oncotarget 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.